The U.S. Food and Drug Administration on Thursday announced a new program to speed up construction and review of drug ...

Vinay Prasad is once again head of the FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign ...

Sarepta shares dropped as much as 5.2 per cent on Monday amid volatile trading, while those of Replimune — another gene ...

Trump’s first term also had an enduring impact on the courts, appointing 234 judges. By the end of that term, more than ...

Washington DC mayor Muriel Bowser has hit back at Donald Trump over how he has painted the DC crime rate and threats to drop ...

Vinay Prasad, the U.S. Food and Drug Administration's top vaccine regulator, is returning to his post less than two weeks ...

Vinay Prasad, MD, MPH, is resuming leadership of the FDA center that regulates vaccines and biotech therapies, an HHS ...

Vinay Prasad, a professor who until earlier this year headed a cancer-drugs and health-policy lab at UC San Francisco, ...

An FDA official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to ...

Dr. Vinay Prasad was rehired Saturday to lead the FDA's Center for Biologics Evaluation and Research less than two weeks ...

The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...